- Home
- BEDU vs MAIA Comparison
BEDU vs MAIA Comparison
Compare BEDU & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- MAIA
- Stock Information
- Founded
- BEDU 1994
- MAIA 2018
- Country
- BEDU United Kingdom
- MAIA United States
- Employees
- BEDU N/A
- MAIA N/A
- Industry
- BEDU Other Consumer Services
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- MAIA Health Care
- Exchange
- BEDU Nasdaq
- MAIA Nasdaq
- Market Cap
- BEDU 47.7M
- MAIA 46.7M
- IPO Year
- BEDU 2017
- MAIA 2022
- Fundamental
- Price
- BEDU $1.65
- MAIA $1.79
- Analyst Decision
- BEDU
- MAIA
- Analyst Count
- BEDU 0
- MAIA 0
- Target Price
- BEDU N/A
- MAIA N/A
- AVG Volume (30 Days)
- BEDU 6.8K
- MAIA 371.3K
- Earning Date
- BEDU 08-01-2025
- MAIA 08-08-2025
- Dividend Yield
- BEDU N/A
- MAIA N/A
- EPS Growth
- BEDU N/A
- MAIA N/A
- EPS
- BEDU N/A
- MAIA N/A
- Revenue
- BEDU $224,321,752.00
- MAIA N/A
- Revenue This Year
- BEDU N/A
- MAIA N/A
- Revenue Next Year
- BEDU N/A
- MAIA N/A
- P/E Ratio
- BEDU N/A
- MAIA N/A
- Revenue Growth
- BEDU N/A
- MAIA N/A
- 52 Week Low
- BEDU $1.35
- MAIA $1.40
- 52 Week High
- BEDU $2.41
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- BEDU 43.95
- MAIA 47.69
- Support Level
- BEDU $1.70
- MAIA $1.66
- Resistance Level
- BEDU $1.93
- MAIA $1.95
- Average True Range (ATR)
- BEDU 0.04
- MAIA 0.10
- MACD
- BEDU -0.02
- MAIA -0.00
- Stochastic Oscillator
- BEDU 0.00
- MAIA 23.28
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.